The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: A novel mechanism of regulation of IL-1 responsiveness

被引:0
|
作者
Lang, D
Knop, J
Wesche, H
Raffetseder, U
Kurrle, R
Boraschi, D
Martin, MU
机构
[1] Med Hsch Hannover, Inst Mol Pharmakol, D-30623 Hannover, Germany
[2] Hoechst Marion Roussel, DG Rheumatol, Wiesbaden, Germany
[3] Dompe Res Ctr, I-67100 Laquila, Italy
来源
JOURNAL OF IMMUNOLOGY | 1998年 / 161卷 / 12期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-1 binds to two types of receptors on the cell membrane, of which only type I (IL-1RI) transduces signals in concert with the coreceptor IL-1 receptor accessory protein (IL-1RAcP) while type II (IL-1RII) allegedly functions solely as ligand sink and decoy receptor without participating in IL-1 signaling. To investigate the regulatory Role of IL-1RII on IL-1 responsiveness, a chimeric receptor encompassing the extracellular and transmembrane portions of IL-1RII and the cytoplasmic signal-transducing domain of IL-1RI was transfected into two murine EL-4-derived sublines that do or do not express IL-1RAcP, respectively. The chimeric receptor was able to transduce the IL-1 signal and induce IL-2 production only in the cell line which expressed IL-1RAcP, suggesting effective interaction between the extracellular domains of IL-1RII and IL-1RAcP in the presence of IL-1, The physical association of ligated IL-1RII with IL-1RAcP was proven by crosslinking experiments with radio-iodinated IL-l and subsequent immunoprecipitations in normal human B cells and in EL-4 D6/76 cells transiently cotransfected with IL-1RII and IL-1RAcP, respectively. Based on these findings, it is proposed that upon IL-1 binding IL-1RII can recruit IL-1RAcP into a nonfunctional trimeric complex and thus modulate IL-1 signaling by subtracting the coreceptor molecule from the signaling IL-1RI, In this novel mechanism of coreceptor competition, the ratio between IL-1RII and IL-1RI becomes the central factor in determining the IL-1 responsiveness of a cell and the availability of IL-1RAcP becomes limiting for effective IL-1 signaling.
引用
收藏
页码:6871 / 6877
页数:7
相关论文
共 50 条
  • [21] The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type IIIL-1 receptor to inhibit IL-1 action
    Smith, DE
    Hanna, R
    Friend, D
    Moore, H
    Chen, H
    Farese, AM
    MacVittie, TJ
    Virca, GD
    Sims, JE
    IMMUNITY, 2003, 18 (01) : 87 - 96
  • [22] IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein
    Jensen, LE
    Muzio, M
    Mantovani, A
    Whitehead, AS
    JOURNAL OF IMMUNOLOGY, 2000, 164 (10): : 5277 - 5286
  • [23] Interleukin-1α (IL-1α), IL-1β, IL-1 receptor type I, IL-1 receptor antagonist, and TGF-β1 mRNAs in pediatric astrocytomas, ependymomas, and primitive neuroectodermal tumors
    Ilyin, SE
    Gonzalez-Gomez, I
    Gilles, FH
    Plata-Salaman, CR
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1998, 33 (02) : 125 - 137
  • [24] Roles of IL-1 and IL-1 receptor antagonist in the immune system
    Horai, R
    Asano, M
    Nakae, S
    Saijo, S
    Sudo, K
    Iwakura, Y
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 380 - 380
  • [25] Crystal structure of an IL-1 receptor antagonist peptide complexed with IL-1 receptor type I
    Brandhuber, BJ
    Dripps, DJ
    Edwards, CK
    Vigers, GPA
    FASEB JOURNAL, 2000, 14 (08): : A1394 - A1394
  • [26] A 7 amino acid motif in the IL-1 receptor accessory protein cytoplasmic tail is critical for IL-1 signaling
    Korherr, C
    Hofmeister, R
    Luger, K
    Gabler, S
    Falk, W
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 379 - 379
  • [27] Genetic control of IL-1β bioactivity through differential regulation of the IL-1 receptor antagonist
    Vamvakopoulos, J
    Green, C
    Metcalfe, S
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (10) : 2988 - 2996
  • [28] ELEVATED LEVELS OF SHED TYPE-II IL-1 RECEPTOR IN SEPSIS - POTENTIAL ROLE FOR TYPE-II RECEPTOR IN REGULATION OF IL-1 RESPONSES
    GIRI, JG
    WELLS, J
    DOWER, SK
    MCCALL, CE
    GUZMAN, RN
    SLACK, J
    BIRD, TA
    SHANEBECK, K
    GRABSTEIN, KH
    SIMS, JE
    ALDERSON, MR
    JOURNAL OF IMMUNOLOGY, 1994, 153 (12): : 5802 - 5809
  • [29] Immunohistochemical staining of IL-1 alpha and IL-1 receptor antagonist but not IL-1 beta in cultures of Sertoli cells
    Huleihel, M
    Zeyse, D
    Lunenfeld, E
    Beck, M
    Prinsloo, I
    Potashnik, G
    Mazor, M
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2001, 45 (03) : 135 - 141
  • [30] Human Colon Carcinomas Constitutively Express and Shed Type II IL-1 Receptor, an IL-1 Antagonist
    Andrew W. Stadnyk
    Moorix M.W. Yeung
    Sen Rong Yan
    Digestive Diseases and Sciences, 2003, 48 : 1737 - 1744